MC
0
Active Trials
1
Total Trials
0
Organizations
0
Events

Monaco

Medical Only (Private)

Reimbursed Care Access

Monaco maintains a restrictive controlled‑substances regime: classic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) are treated as illicit with no routine medical programs outside approved research. Esketamine (Spravato) is authorised at the European level and therefore may be prescribed/obtained within Monaco subject to national/ministerial marketing and reimbursement decisions; racemic ketamine is used off‑label in psychiatric practice in Europe but access is typically private and not routinely reimbursed without specific ministerial listing or exceptional procedures.

Clinical Trials in Monaco

Research Events